
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Medidata and ICON announced a new collaboration to enhance the management of medical imaging during drug development research for sponsors and sites during clinical trials. This new imaging technology will allow their customers to gain the added benefit of real time image access which will ultimately speed up clinical trials.
Read the full release






